Z15.03

Clinical Causes: Inherited genetic mutations that increase cancer risk Family history of prostate or other related cancers Specific gene alterations linked to prostate cancer, such as BRCA1 and BRCA2 mutations Genetic syndromes associated with increased cancer risk

Key Symptoms: In many cases, early prostate cancer may not cause noticeable symptoms Possible symptoms if the cancer progresses include urinary difficulties, such as difficulty urinating or a weak urine stream Blood in the urine or semen Pain in the pelvis, back, or hips Erectile dysfunction Unexplained weight loss or fatigue in advanced stages

Diagnosis Path: Diagnosis typically involves a combination of prostate-specific antigen (PSA) blood tests, digital rectal examinations (DRE), and imaging studies. A biopsy is often performed to confirm the presence of malignant cells. For individuals with a family history or genetic predisposition, genetic testing may be recommended to identify specific mutations associated with increased risk.

Treatment Protocols: While this diagnosis focuses on genetic susceptibility, management strategies might include regular screening and early detection efforts. Treatment options once prostate cancer develops can include surgery, radiation therapy, hormone therapy, chemotherapy, or targeted therapy. The approach depends on the cancer stage, overall health, and personal preferences. Preventive measures may involve lifestyle modifications and vigilant monitoring for early signs of disease.